|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| A61K 31/713 | (2006.01) |
| (11) | Number of the document | 3444349 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18183735.2 |
| Date of filing the European patent application | 2015-05-27 | |
| (97) | Date of publication of the European application | 2019-02-20 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-06 |
| (46) | Date of publication of the claims translation | 2021-04-12 |
| (30) | Number | Date | Country code |
| 201462004239 P | 2014-05-29 | US |
| (72) |
Squiers, Elizabeth C., US
Erlich, Shai, US
Rothenstein, Daniel, IL
Sharon, Nir, IL
Odenheimer, Daniel J., US
Feinstein, Elena, IL
|
| (73) |
Quark Pharmaceuticals, Inc.,
7999 Gateway Boulevard, Suite 310, Newark, CA 94560,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Būdai ir kompozicijos, skirti išeminio reperfuzinio pažeidimo organuose prevencijai |
| METHODS AND COMPOSITIONS FOR PREVENTING ISCHEMIA REPERFUSION INJURY IN ORGANS |
| Payment date | Validity (years) | Amount | |
| 2021-04-22 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-05-27 |